Triple-negative breast cancer (TNBC) is a breast cancer subtype defined by its lack of an estrogen receptor (ER) and progesterone receptor (PR), and the absence of amplification of human epidermal growth factor receptors 2 (HER-2) [1]. This evidence concerns the gene ESR1 and breast cancer.